HomeLRMR • NASDAQ
add
Larimar Therapeutics Inc
Previous close
$4.57
Day range
$4.57 - $4.83
Year range
$1.61 - $6.42
Market cap
486.17M USD
Avg Volume
7.22M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 64.02M | 104.58% |
Net income | -62.50M | -116.83% |
Net profit margin | — | — |
Earnings per share | -0.73 | -62.22% |
EBITDA | -63.93M | -104.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 136.85M | -25.40% |
Total assets | 145.84M | -27.16% |
Total liabilities | 67.76M | 138.47% |
Total equity | 78.08M | — |
Shares outstanding | 103.88M | — |
Price to book | 4.86 | — |
Return on assets | -96.07% | — |
Return on capital | -141.92% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -62.50M | -116.83% |
Cash from operations | -38.53M | -76.61% |
Cash from investing | 34.00M | 77.11% |
Cash from financing | -201.00K | -658.33% |
Net change in cash | -4.73M | -83.11% |
Free cash flow | -16.02M | -39.17% |
About
Founded
2005
Headquarters
Website
Employees
71
